These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29352227)

  • 21. Differential α4(+)/(-)β2 Agonist-binding Site Contributions to α4β2 Nicotinic Acetylcholine Receptor Function within and between Isoforms.
    Lucero LM; Weltzin MM; Eaton JB; Cooper JF; Lindstrom JM; Lukas RJ; Whiteaker P
    J Biol Chem; 2016 Jan; 291(5):2444-59. PubMed ID: 26644472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. des-Formylflustrabromine (dFBr): A Structure-Activity Study on Its Ability To Potentiate the Action of Acetylcholine at α4β2 Nicotinic Acetylcholine Receptors.
    Dukat M; Jain A; German N; Ferrara-Pontoriero R; Huang Y; Ma Y; Schulte MK; Glennon RA
    ACS Chem Neurosci; 2018 Dec; 9(12):2984-2996. PubMed ID: 30028943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinctive single-channel properties of α4β2-nicotinic acetylcholine receptor isoforms.
    Weltzin MM; George AA; Lukas RJ; Whiteaker P
    PLoS One; 2019; 14(3):e0213143. PubMed ID: 30845161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The unique α4+/-α4 agonist binding site in (α4)3(β2)2 subtype nicotinic acetylcholine receptors permits differential agonist desensitization pharmacology versus the (α4)2(β2)3 subtype.
    Eaton JB; Lucero LM; Stratton H; Chang Y; Cooper JF; Lindstrom JM; Lukas RJ; Whiteaker P
    J Pharmacol Exp Ther; 2014 Jan; 348(1):46-58. PubMed ID: 24190916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the Cys Loop and Transmembrane Domain in the Allosteric Modulation of α4β2 Nicotinic Acetylcholine Receptors.
    Alcaino C; Musgaard M; Minguez T; Mazzaferro S; Faundez M; Iturriaga-Vasquez P; Biggin PC; Bermudez I
    J Biol Chem; 2017 Jan; 292(2):551-562. PubMed ID: 27864368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Novel α2/α4 Subtype-selective Positive Allosteric Modulator of Nicotinic Acetylcholine Receptors Acting from the C-tail of an α Subunit.
    Wang J; Kuryatov A; Jin Z; Norleans J; Kamenecka TM; Kenny PJ; Lindstrom J
    J Biol Chem; 2015 Nov; 290(48):28834-46. PubMed ID: 26432642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two distinct allosteric binding sites at α4β2 nicotinic acetylcholine receptors revealed by NS206 and NS9283 give unique insights to binding activity-associated linkage at Cys-loop receptors.
    Olsen JA; Kastrup JS; Peters D; Gajhede M; Balle T; Ahring PK
    J Biol Chem; 2013 Dec; 288(50):35997-6006. PubMed ID: 24169695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positive allosteric modulation of α4β2 nicotinic acetylcholine receptors as a new approach to smoking reduction: evidence from a rat model of nicotine self-administration.
    Liu X
    Psychopharmacology (Berl); 2013 Nov; 230(2):203-13. PubMed ID: 23712602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular interactions of type I and type II positive allosteric modulators with the human α7 nicotinic acetylcholine receptor: an in silico study.
    Targowska-Duda KM; Kaczor AA; Jozwiak K; Arias HR
    J Biomol Struct Dyn; 2019 Feb; 37(2):411-439. PubMed ID: 29363414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potentiation of alpha7 nicotinic acetylcholine receptors via an allosteric transmembrane site.
    Young GT; Zwart R; Walker AS; Sher E; Millar NS
    Proc Natl Acad Sci U S A; 2008 Sep; 105(38):14686-91. PubMed ID: 18791069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Covalent trapping of methyllycaconitine at the α4-α4 interface of the α4β2 nicotinic acetylcholine receptor: antagonist binding site and mode of receptor inhibition revealed.
    Absalom NL; Quek G; Lewis TM; Qudah T; von Arenstorff I; Ambrus JI; Harpsøe K; Karim N; Balle T; McLeod MD; Chebib M
    J Biol Chem; 2013 Sep; 288(37):26521-32. PubMed ID: 23893416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engineered α4β2 nicotinic acetylcholine receptors as models for measuring agonist binding and effect at the orthosteric low-affinity α4-α4 interface.
    Ahring PK; Olsen JA; Nielsen EØ; Peters D; Pedersen MH; Rohde LA; Kastrup JS; Shahsavar A; Indurthi DC; Chebib M; Gajhede M; Balle T
    Neuropharmacology; 2015 May; 92():135-45. PubMed ID: 25595102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human alpha4beta2 acetylcholine receptors formed from linked subunits.
    Zhou Y; Nelson ME; Kuryatov A; Choi C; Cooper J; Lindstrom J
    J Neurosci; 2003 Oct; 23(27):9004-15. PubMed ID: 14534234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allosteric modulation of alpha4beta2 nicotinic acetylcholine receptors by HEPES.
    Weltzin MM; Huang Y; Schulte MK
    Eur J Pharmacol; 2014 Jun; 732():159-68. PubMed ID: 22732654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Additional acetylcholine (ACh) binding site at alpha4/alpha4 interface of (alpha4beta2)2alpha4 nicotinic receptor influences agonist sensitivity.
    Mazzaferro S; Benallegue N; Carbone A; Gasparri F; Vijayan R; Biggin PC; Moroni M; Bermudez I
    J Biol Chem; 2011 Sep; 286(35):31043-31054. PubMed ID: 21757735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficient binding of 4/7 α-conotoxins to nicotinic α4β2 receptors is prevented by Arg185 and Pro195 in the α4 subunit.
    Beissner M; Dutertre S; Schemm R; Danker T; Sporning A; Grubmüller H; Nicke A
    Mol Pharmacol; 2012 Oct; 82(4):711-8. PubMed ID: 22802270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acetylcholine and alcohol sensitivity of neuronal nicotinic acetylcholine receptors: mutations in transmembrane domains.
    Borghese CM; Ali DN; Bleck V; Harris RA
    Alcohol Clin Exp Res; 2002 Dec; 26(12):1764-72. PubMed ID: 12500099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute Administration of Desformylflustrabromine Relieves Chemically Induced Pain in CD-1 Mice.
    Weggel LA; Pandya AA
    Molecules; 2019 Mar; 24(5):. PubMed ID: 30866543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potentiation of a neuronal nicotinic receptor via pseudo-agonist site.
    Mazzaferro S; Bermudez I; Sine SM
    Cell Mol Life Sci; 2019 Mar; 76(6):1151-1167. PubMed ID: 30600358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of desformylflustrabromine and its evaluation as an alpha4beta2 and alpha7 nACh receptor modulator.
    Kim JS; Padnya A; Weltzin M; Edmonds BW; Schulte MK; Glennon RA
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4855-60. PubMed ID: 17604168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.